Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cytotherapy

Showing results (891-900 of 2,791) with videos related to

Pageof 280
Sort By:
Cytotherapy|June 4, 2002
Low oxygen tension enhances the stimulation and proliferation of human T lymphocytes in the presence of IL-2K S Carswell, J W Weiss, E T Papoutsakis
Cytotherapy|May 15, 2002
CliniMACS CD34-selected cells to support multiple cycles of high-dose therapyH M Prince, D Wall, D Rischin, et al.
Cytotherapy|May 15, 2002
Immune escape mechanisms of childhood ALL and a potential countering role for DC-like leukemia cellsP Han, C Story, T McDonald, et al.
Cytotherapy|May 25, 2002
Expansion of megakaryocyte progenitors from cryopreserved leukocyte concentrates of human placental and umbilical cord blood in short-term liquid cultureN Sasayama, I Kashiwakura, Y Tokushima, et al.
Cytotherapy|May 25, 2002
Accurate calculation of blood volume to be processed by apheresis to achieve target CD34+ cell numbers for PBPC transplantationA E Trickett, S Smith, Y L Kwan
Cytotherapy|May 25, 2002
Development of a clinical-scale method for generation of dendritic cells from PBMC for use in cancer immunotherapyE C Wong, V E Maher, K Hines, et al.
Cytotherapy|May 25, 2002
Adhesion of MNC to extracellular matrix proteins following in vitro photochemotherapyP Perutelli, S Murugesan, G Dini
Cytotherapy|May 15, 2002
Isolex 300i CD34-selected cells to support multiple cycles of high-dose therapyH M Prince, J Bashford, D Wall, et al.
Cytotherapy|August 29, 2003
Regulation of cellular therapies: the Australian perspectiveD M P Wall, H M Prince
Cytotherapy|August 29, 2003
The impact of escalating regulatory requirements on the conduct of clinical researchB G Gordon, A Kessinger, S L Mann, et al.
Pageof 280

Showing results (891-900 of 2,791) with videos related to

Sort By:
Pageof 280
Cytotherapy|June 4, 2002
Low oxygen tension enhances the stimulation and proliferation of human T lymphocytes in the presence of IL-2K S Carswell, J W Weiss, E T Papoutsakis
Cytotherapy|May 15, 2002
CliniMACS CD34-selected cells to support multiple cycles of high-dose therapyH M Prince, D Wall, D Rischin, et al.
Cytotherapy|May 15, 2002
Immune escape mechanisms of childhood ALL and a potential countering role for DC-like leukemia cellsP Han, C Story, T McDonald, et al.
Cytotherapy|May 25, 2002
Expansion of megakaryocyte progenitors from cryopreserved leukocyte concentrates of human placental and umbilical cord blood in short-term liquid cultureN Sasayama, I Kashiwakura, Y Tokushima, et al.
Cytotherapy|May 25, 2002
Accurate calculation of blood volume to be processed by apheresis to achieve target CD34+ cell numbers for PBPC transplantationA E Trickett, S Smith, Y L Kwan
Cytotherapy|May 25, 2002
Development of a clinical-scale method for generation of dendritic cells from PBMC for use in cancer immunotherapyE C Wong, V E Maher, K Hines, et al.
Cytotherapy|May 25, 2002
Adhesion of MNC to extracellular matrix proteins following in vitro photochemotherapyP Perutelli, S Murugesan, G Dini
Cytotherapy|May 15, 2002
Isolex 300i CD34-selected cells to support multiple cycles of high-dose therapyH M Prince, J Bashford, D Wall, et al.
Cytotherapy|August 29, 2003
Regulation of cellular therapies: the Australian perspectiveD M P Wall, H M Prince
Cytotherapy|August 29, 2003
The impact of escalating regulatory requirements on the conduct of clinical researchB G Gordon, A Kessinger, S L Mann, et al.
Pageof 280